Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Kurni Kurniyati *Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, VA, USA.
Nicholas D Clark *Department of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, the State University of New York, Buffalo, NY, USA.ORCID http://orcid.org/0000-0002-5939-736X
Hongxia WangPhilips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, VA, USA.
Yijie DengPhilips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, VA, USA.
Ching Wooen SzePhilips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, VA, USA.
Michelle B VisserDepartment of Oral Biology, School of Dentistry, University of Buffalo, the State University of New York, Buffalo, NY, USA.
Michael G MalkowskiDepartment of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, the State University of New York, Buffalo, NY, USA. mgm22@buffalo.edu.ORCID http://orcid.org/0000-0002-1203-7463
Chunhao LiPhilips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, VA, USA. cli5@vcu.edu.ORCID http://orcid.org/0000-0002-1872-4870
Funding
Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Renato Martins · 1985 to 2026
$51.0M
X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Vivian Stojanoff · 2019 to 2026
$38.6M
User Training & OutreachP30GM138396 · NIGMS · UCHICAGO ARGONNE, LLC · PI ROBERT F. FISCHETTI · 2020 to 2026
$34.3M
Exploring New Virulence Factors of the Oral Spirochete Treponema denticolaR01DE023080 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI Chunhao Chris Li · 2013 to 2026
$5.2M
Enabling Access to Cutting-Edge Biomedical and Behavioral ScienceR25GM095459 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DUBOCOVICH, MARGARITA L · 2012 to 2021
$4.4M
Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalisR01DE030667 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, CHUNHAO CHRIS · 2021 to 2025
$2.4M
High-Speed High-Sensitivity Detector for X-ray Micro-Crystallography at GM/CA@APSS10OD012289 · OD · UNIVERSITY OF CHICAGO · PI FISCHETTI, ROBERT F. · 2014 to 2014
$2.0M
The role of oral spirochete virulence factors in the impairment of neutrophil responseR01DE027073 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI VISSER, MICHELLE B · 2018 to 2023
$2.0M
Decoding the glycome of oral Treponema denticolaR01DE034063 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI Chunhao Chris Li · 2024 to 2026
$1.5M
A Simultaneous SAXS/WAXS Detector System for Solving Biological StructuresS10OD012331 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI ALLAIRE, MARC · 2012 to 2012
$1.1M
Acquisition of a Hybrid Quadrupole Time of Flight LC-MS/MS System for the CornellS10OD017992 · OD · CORNELL UNIVERSITY · PI ZHANG, SHENG · 2014 to 2014
$600k
HHS | NIH | National Cancer Institute (NCI) ACB-12002HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR) DE023080HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR) DE027073HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR) DE030667HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR) DE034063HHS | NIH | National Institute of General Medical Sciences (NIGMS) 1S10 OD017992HHS | NIH | National Institute of General Medical Sciences (NIGMS) AGM-12006HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM095459NCI NIH HHS P30 CA016059NIDCR NIH HHS R01 DE023080NIDCR NIH HHS R01 DE027073NIDCR NIH HHS R01 DE030667NIDCR NIH HHS R01 DE034063NIGMS NIH HHS P30 GM133893NIGMS NIH HHS P30 GM138396NIGMS NIH HHS R25 GM095459NIH HHS S10 OD012289NIH HHS S10 OD012331NIH HHS S10 OD017992ODCDC CDC HHS S10 OD012289U.S. Department of Energy (DOE) DE-SC0012704
6 · The paper itself
Abstract
The complement system and neutrophils constitute the two main pillars of the host innate immune defense against infection by bacterial pathogens. Here, we identify T-Mac, a novel virulence factor of the periodontal pathogen Treponema denticola that allows bacteria to evade both defense systems. We show that T-Mac is expressed as a pre-protein that is cleaved into two functional units. The N-terminal fragment has two immunoglobulin-like domains and binds with high affinity to the major neutrophil chemokine receptors FPR1 and CXCR1, blocking N-formyl-Met-Leu-Phe- and IL-8-induced neutrophil chemotaxis and activation. The C-terminal fragment functions as a cysteine protease with a unique proteolytic activity and structure, which degrades several components of the complement system, such as C3 and C3b. Murine infection studies further reveal a critical T-Mac role in tissue damage and inflammation caused by bacterial infection. Collectively, these results disclose a novel innate immunity-evasion strategy, and open avenues for investigating the role of cysteine proteases and immunoglobulin-like domains of gram-positive and -negative bacterial pathogens.
Indexed as
Bacterial ProteinsComplement System ProteinsNeutrophil ActivationNeutrophilsTreponema denticolaVirulence FactorsAnimalsHumansImmune EvasionImmunity, InnateMiceBacterial ProteinsComplement System ProteinsVirulence FactorsComplement SystemCysteine ProteaseImmune EvasionImmunoglobulin-like DomainNeutrophils
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A bipartite bacterial virulence factor targets the complement system and neutrophil activation. · full record | OpenQuestion